- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02027792
Cabbage Leaf Wraps in Osteoarthritis of the Knee (KoGon)
April 30, 2018 updated by: Romy Lauche, Universität Duisburg-Essen
Randomised Controlled Trial on the Efficacy of Cabbage Leaf Wraps in Symptomatic Primary Osteoarthritis of the Knee
This randomised controlled trial aims to investigate the efficacy of cabbage leaf cataplasms in the treatment of primary symptomatic osteoarthritis of the knee.
81 patients will be randomised into one of 3 groups and apply either cabbage leaf cataplasm or diclofenac gel daily for 4 weeks or receive only usual care.
Efficacy will be measured using questionnaire on pain, disability, quality of life and pressure pain sensitivity.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
81
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Essen, Germany, 45276
- Department of Internal and Integrative Medicine, Kliniken Essen-Mitte
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- osteoarthritis of the knee, Kellgren Lawrence stadium 2-3
- at least 50% of days with complaints
- initial pain intensity 45mm on a 100mm visual analoge scale
Exclusion Criteria:
- medication with corticoids or immunsupressing drugs
- secondary arthritis/arthrosis
- operation to the knee within 12 months prior
- injection within 4 weeks (cortison) or 6 months prior (hyaluronic acid)
- severe comorbidities (liver, kidney, asthma, psychiatric disorders etc.)
- participation in other studies
- pregnancy, breastfeeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual care
no specific intervention
|
|
Experimental: Cabbage leaf wraps
Daily application of cabbage leaf wraps over night, 4 weeks application
|
|
Active Comparator: Diclofenac gel
daily application of diclofenac gel 4 weeks application
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain intensity
Time Frame: 4 weeks
|
pain intensity measured on three 0-100mm visual analog scales (actual, mean, worst pain)
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
knee function (WOMAC)
Time Frame: 4 weeks
|
physical everyday function using the validated WOMAC questionnaire
|
4 weeks
|
Quality of Life (SF-36)
Time Frame: 4 weeks
|
health related quality of life with the validated SF-36 questionnaire
|
4 weeks
|
self-efficacy (ASES-D)
Time Frame: 4 weeks
|
self-efficacy with the arthritis specific self efficacy scale in German
|
4 weeks
|
physical function (30second chair test)
Time Frame: 4 weeks
|
validated test to measure how often patients can stand up from a chair in 30 seconds)
|
4 weeks
|
Pressure pain sensitivity
Time Frame: 4 weeks
|
measured by an algometer at predefined areas
|
4 weeks
|
knee function (WOMAC)
Time Frame: 12 weeks
|
physical everyday function using the validated WOMAC questionnaire
|
12 weeks
|
Quality of Life (SF-36)
Time Frame: 12 weeks
|
health related quality of life with the validated SF-36 questionnaire
|
12 weeks
|
self-efficacy (ASES-D)
Time Frame: 12 weeks
|
self-efficacy with the arthritis specific self efficacy scale in German
|
12 weeks
|
Adverse events
Time Frame: 4 weeks
|
Safety measure
|
4 weeks
|
physical function (30second chair test)
Time Frame: 12 weeks
|
validated test to measure how often patients can stand up from a chair in 30 seconds)
|
12 weeks
|
Pressure pain sensitivity
Time Frame: 12 weeks
|
measured by an algometer at predefined areas
|
12 weeks
|
Adverse events
Time Frame: 12 weeks
|
Safety measure
|
12 weeks
|
Pain intensity
Time Frame: 12 weeks
|
pain intensity measured on three 0-100mm visual analog scales (actual, mean, worst pain)
|
12 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Course of Pain
Time Frame: 12 weeks
|
measured by a diary including pain intensity on a visual analogue scale, medication
|
12 weeks
|
Satisfaction
Time Frame: 20 weeks
|
Satisfaction with either treatments
|
20 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (Actual)
August 1, 2014
Study Completion (Actual)
August 1, 2014
Study Registration Dates
First Submitted
January 3, 2014
First Submitted That Met QC Criteria
January 3, 2014
First Posted (Estimate)
January 6, 2014
Study Record Updates
Last Update Posted (Actual)
May 2, 2018
Last Update Submitted That Met QC Criteria
April 30, 2018
Last Verified
April 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Joint Diseases
- Musculoskeletal Diseases
- Rheumatic Diseases
- Arthritis
- Osteoarthritis
- Osteoarthritis, Knee
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Diclofenac
Other Study ID Numbers
- 13-5581 KoGon
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis of the Knee
-
Taiwan Liposome CompanyCompletedOSTEOARTHRITIS OF THE KNEETaiwan, United States
-
University Hospital, GhentCompletedOsteoarthritis of the Knee JointBelgium
-
Bone Therapeutics S.ANordic Bioscience A/SCompletedSymptomatic Osteoarthritis of the KneeDenmark, Belgium, United Kingdom, Czechia, Hong Kong, Moldova, Republic of, Poland
-
Rush University Medical CenterWithdrawnSymptomatic Osteoarthritis of the Knee
-
Region SkaneRecruitingOsteoarthritis of the Knee or HipSweden
-
UMC UtrechtCompletedMedial Compartment Osteoarthritis of the KneeNetherlands
-
Massachusetts General HospitalGöteborg University; Seoul National University Hospital; Ulsan University Hospital and other collaboratorsUnknownOsteoarthritis of the Knee | Traumatic Arthritis of the KneeUnited States
-
Ampio Pharmaceuticals. Inc.TerminatedSevere Osteoarthritis of the KneeUnited States
-
Ampio Pharmaceuticals. Inc.TerminatedSevere Osteoarthritis of the KneeUnited States
-
Hospital General de Jerez de la FronteraZiekenhuis Oost-LimburgCompletedPainful Osteoarthritis of the KneeSpain
Clinical Trials on Cabbage leave wraps
-
Colorado State UniversityCompleted
-
Oslo University HospitalHelse Sor-OstUnknown
-
University Hospital, LilleMinistry of Health, FranceCompletedAutism Spectrum DisorderFrance
-
University of Roma La SapienzaRecruiting
-
Virginia Commonwealth UniversityCompleted
-
Istituto Ortopedico RizzoliCompleted
-
Fundación Oftalmológica de Santander Clínica Carlos...Universidad Industrial de Santander; Clinica ChicamochaUnknownLung Diseases, Interstitial | Pulmonary Nodule, SolitaryColombia
-
University Hospital, ToulouseNot yet recruiting
-
Chattem, Inc.CompletedTolerability | Adhesiveness | Dermal Irritation | Effects of HeatUnited States